Flag

An official website of the United States government

Travel Advisory Level 1: Exercise Normal Caution Travel Advisory Level 1: Reissued with updates to health information. Read More...
COVID-19 Information
By
16 MINUTE READ
February 2, 2023

COVID-19 Information 

Last updated: [05/12/2023]

The CDC’s Order requiring proof of vaccination for non-U.S. citizen nonimmigrants to travel to the United States is still in effect until May 11th, 2023. For more information see Requirement for Proof of COVID-19 Vaccination for Air Passengers.

Check the CDC website for additional information and Frequently Asked Questions.

Entry and Exit Requirements:

  • Are U.S. citizens permitted to enter? Yes.
  • Is a negative COVID-19 test (PCR and/or serology) required for entry? No.
    • If a traveler is suspected or reported to be infected with COVID-19 at the port of entry, the same preventions and controls will apply as if it were any other acute respiratory condition.
    • Multiple countries in the region have implemented travel restrictions with little advance notice.  To stay informed of the latest travel restrictions, visit the U.S. Embassy COVID-19 webpage for the country of your intended destination or stopover.
    • See the Government order here.
  • Are health screening procedures in place at airports and other ports of entry? No.

Quarantine Information:

  • Are U.S. citizens required to quarantine? No (dependent upon circumstances).
    • Federal guidelines for positive cases can be found here.
    • If you test positive and are not living or working with someone in a high-risk group, it is recommended that you stay home while you have symptoms, do not work or engage in social activities, and seek medical advice if your symptoms persist or get worse. For 10 days after the first appearance of symptoms do not attend large events, use a mask, ventilate your space, wash your hands frequently, and cover your cough or sneeze.
    • If you live or work with vulnerable populations, seek medical advice.
  • Note: The above information is based on the most recent Argentine federal government guidelines.  Local guidelines may differ, and the length and location of isolation or quarantine will be determined by local health officials and may vary depending on individual cases and circumstances. For example, in the City of Buenos Aires (CABA):
    • Confirmed cases must isolate for 5 days from the date of onset of symptoms, or in asymptomatic cases, from the date of diagnosis, plus 5 days of special care (not attend large events or social gatherings, use of face mask at all times where there are other people, social distance).
    • Individuals who have close contact with a positive case are recommended to wear a face mask in public, avoid large social events, avoid contact with vulnerable people, and monitor themselves for symptoms for 10 days.
  • Note: The costs associated with lodging and other expenses during the isolation period are the responsibility of the traveler and may involve peak season lodging rates and other expenses.  Please note that the determination of close contact is made by local health officials and may include extended family members and other individuals within a tour group or traveling party.

COVID-19 Testing:

Are PCR and /or antigen tests available for U.S. citizens in Argentina? Yes.

If so, are test results reliably available within one calendar day? Yes.

    • Within the City of Buenos Aires, if using a private lab, results are generally available within 24 hours.  If using a public hospital, the time frame for receiving results can vary between eight and 72 hours.  Please note that private and public facilities may experience delays in returning test results if demand for tests increases.
    • Test results are generally provided electronically.  Test results are provided in Spanish.

COVID-19 Vaccine Information:

  • Has the government of Argentina approved a COVID-19 vaccine for use? Yes
  • Are vaccines available in Argentina for U.S. citizens to receive? Yes 
    • Which vaccines are available in Argentina?
      • The Government of Argentina has approved the Russian Sputnik V vaccine, the University of Oxford/AstraZeneca vaccine, the Convidecia CanSinoBiologics vaccine, the Comirnaty Pfizer/BioNTech vaccine, the Moderna vaccine, the Sinopharm Sinovac vaccine, the Covishield vaccine, and the Johnson and Johnson vaccine for use against COVID-19.  In Argentina, U.S. citizens should check with local health officials or their local health provider and may also review the information available on this website.  This website provides information on vaccination rollout status, eligibility criteria and links to each jurisdiction to register for vaccines.
    • Visit the FDA’s website to learn more about FDA-approved vaccines in the United States.
    • The U.S. government does not plan to provide COVID-19 vaccinations to private U.S. citizens overseas.  Please follow host country developments and guidelines for COVID-19 vaccination.

Movement Restrictions:

  • Is a curfew in place? No
    • Anyone residing or traveling in Argentina should consult with local authorities for the most up to date information regarding the status of each city or department as they may move between mandatory quarantine and social distancing measures depending on the current conditions.  For more information, visit this page (in Spanish).
  • Are there restrictions on intercity or interstate travel? No
    • Additional information about interprovincial travel can be found here  (In Spanish).  Individual provinces may require additional local permits to enter or transit.

Local Resources:

Alerts